GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clearbridge Health Ltd (SGX:1H3) » Definitions » COGS-to-Revenue

Clearbridge Health (SGX:1H3) COGS-to-Revenue : 0.49 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Clearbridge Health COGS-to-Revenue?

Clearbridge Health's Cost of Goods Sold for the six months ended in Dec. 2023 was S$2.86 Mil. Its Revenue for the six months ended in Dec. 2023 was S$5.83 Mil.

Clearbridge Health's COGS to Revenue for the six months ended in Dec. 2023 was 0.49.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Clearbridge Health's Gross Margin % for the six months ended in Dec. 2023 was 50.85%.


Clearbridge Health COGS-to-Revenue Historical Data

The historical data trend for Clearbridge Health's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearbridge Health COGS-to-Revenue Chart

Clearbridge Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.67 0.62 0.44 0.42 0.47

Clearbridge Health Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.40 0.44 0.45 0.49

Clearbridge Health COGS-to-Revenue Calculation

Clearbridge Health's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=5.395 / 11.49
=0.47

Clearbridge Health's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=2.863 / 5.825
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clearbridge Health  (SGX:1H3) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Clearbridge Health's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 2.863 / 5.825
=50.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Clearbridge Health COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Clearbridge Health's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearbridge Health (SGX:1H3) Business Description

Traded in Other Exchanges
N/A
Address
37 Jalan Pemimpin, No. 08-05 Mapex, Singapore, SGP, 577177
Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments of the company are Strategic investments; Healthcare systems; Medical clinics; Corporate segment and Investment. It derives key revenue from the Healthcare systems and Medical clinics. The Healthcare systems segment involves, provision of diagnostic services and manufacturing of and research and development on diagnostic related products, and provision of renal care services by partnering with medical device equipment manufacturers and hospitals. The Medical clinics segment involves, provision of general medical and clinical services. The group has a business presence in all over the world.

Clearbridge Health (SGX:1H3) Headlines

No Headlines